MSGNX
Price
$5.19
Change
-$0.01 (-0.19%)
Updated
Sep 11 closing price
Net Assets
681.06M
VEXPX
Price
$130.29
Change
+$1.12 (+0.87%)
Updated
Sep 11 closing price
Net Assets
22.44B
Interact to see
Advertisement

MSGNX vs VEXPX

MSGNX vs VEXPX Comparison Chart in %
View a ticker or compare two or three
VS
MSGNX vs. VEXPX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSGNX is a Hold and VEXPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXPX has more cash in the bank: 22.4B vs. MSGNX (681M). VEXPX pays higher dividends than MSGNX: VEXPX (0.37) vs MSGNX (0.00). MSGNX was incepted earlier than VEXPX: MSGNX (24 years) vs VEXPX (59 years). MSGNX (1.58) is less costly to investors than VEXPX (0.39). MSGNX is a more actively managed with annual turnover of: 76.00 vs. VEXPX (51.00). MSGNX has a lower initial minimum investment than VEXPX: MSGNX (0) vs VEXPX (3000). VEXPX annual gain was more profitable for investors over the last year : 5.94 vs. MSGNX (-24.52). VEXPX return over 5 years is better than : -12.36 vs. MSGNX (-57.27).
MSGNXVEXPXMSGNX / VEXPX
Total Expense Ratio1.550.39397%
Annual Report Gross Expense Ratio1.580.39405%
Fund Existence24 years59 years-
Gain YTD17.89012.508143%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets681M22.4B3%
Annual Yield % from dividends0.000.37-
Returns for 1 year-24.525.94-413%
Returns for 3 years-12.4426.91-46%
Returns for 5 years-57.27-12.36463%
Returns for 10 years-44.3651.20-87%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHSAX63.02N/A
N/A
BlackRock Health Sciences Opps Inv A
MDFOX6.73N/A
N/A
BlackRock Large Cap Focus Growth Inv A
MSACX22.35N/A
N/A
Morgan Stanley Inst Passport ovrs eq I
RYAKX77.62N/A
N/A
Rydex Russell 2000 1.5x Strategy A
VCGRX22.56N/A
N/A
Virtus KAR Capital Growth R6